Review of cholesterol-lowering therapy: Coronary angiographic and events trials

This publication has 32 references indexed in Scilit:

• Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients
  The Lancet, 1994
• Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
  The Lancet, 1994
• Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).
  Circulation, 1994
• Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.
  Circulation, 1994
• Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)
  Annals of Internal Medicine, 1993
• Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
  Circulation, 1992
• Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
  The Lancet, 1992
• Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
  New England Journal of Medicine, 1990
• Published by Massachusetts Medical Society ,1990
• Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
  Circulation, 1984